Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
An update from Trinity Biotech ( (TRIB) ) is now available.
Trinity Biotech plc, an Irish public limited company, has filed a prospectus supplement to its registration statement with the U.S. Securities and Exchange Commission. This filing pertains to the offer and sale of up to $1,000,000 in American Depositary Shares, part of an at-the-market offering agreement with Craig-Hallum Capital Group LLC. The issuance of these shares is contingent upon compliance with corporate actions and receipt of full payment, reflecting the company’s strategic financial maneuvers to potentially enhance liquidity and market presence.
More about Trinity Biotech
YTD Price Performance: -58.18%
Average Trading Volume: 189,298
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $10.21M
See more insights into TRIB stock on TipRanks’ Stock Analysis page.
